Acute myelomonoblastic leukemia carrying the PEBP2β/MYH11 fusion gene

Leukemia and Lymphoma

Volumn 31, Issue 1-2, 1998, Pages 81-91

  Asou, Norio ^a   Osato, Motomi ^a   Okubo, Toshiya ^a   Yamasaki, Hiroshi ^a   Hoshino, Koyu ^a   Nishimura, Shintaro ^a   Era, Takumi ^a   Suzushima, Hitoshi ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Acute myelomonoblastic leukemia; c KIT; CD34; inv(16); M4Eo; PEBP2 MYH11

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ARTICLE; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; MYELOID LEUKEMIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0031711324     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057587     Document Type: Article

References (65)

1. First MIC Cooperative Study Group (1986). Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemia. Cancer Genetics and Cylogenetics, 23, 189-197.
2. Second MIC Cooperative Study Group (1988). Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genetics and Cytogenetics, 30, 1-15.
3. Heim, S. and Mitelman, F. (1995). Cancer cytogenetics, 2nd ed. (Wiley-Liss, Inc., New York) pp. 69-140.
4. Arthur, D. C., Berger, R., Golomb, H. M., Swansbury, G. L., Reeves, B. R., Alimena, G., van den Berghe, H., Bloomfield, C. D., de la Chapelle, A., Dewald, G. W., Garson, O. M., Hagemeijier, A., Kaneko, Y., Mitelman, F., Pierre, R. V., Ruutu, T., Sakurai, M., Lawler, S. D. and Rowley, L. D. (1989). The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genetics and Cytogenetics, 40, 203-216.
5. Schiffer, C. A., Lee, E. J., Tomiyasu, T., Wiernik, P. H. and Testa, J. R. (1989). Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood, 73, 263-270.
6. Swansbury, G. J., Lawler, S. D., Alimena, G., Arthur, D., Berger, R., van den Berghe, H., Bloomfield, C. D., de la Chapelle, A., Dewald, G., Garson, O. M., Hagemeijer, A., Mitelman, F., Rowley, J. D. and Sakurai, M. (1994). Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genetics and Cytogenetics, 73, 1-7.
7. Arthur, D. C. and Bloomfield, C. D. (1983). Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood, 61, 994-998.
8. Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M. and Rowely, J. D. (1983). Association of an inversion of chromosome 16 with abnormal marrow eosinophilia. New England Journal of Medicine, 309, 630-636.
9. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1985). Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 626-629.
10. Larson, R. A., Williams, S. F., Le Beau, M. M., Bitter, M. A., Vardiman, J. W. and Rowely, J. D. (1986). Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16:16) has a favorable prognosis. Blood, 68, 1242-1249.
11. Holmes, R., Keating, M. J., Cork, A., Broach, Y., Trujillo, J., Dalton, J. W. T., McCredie, K. B. and Freireich, E. J. (1985). A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood, 65, 1071-1078.
12. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J. and Collins, F. S. (1993). Fusion between transcriptinal facter CBFβ/PEBP2β and myosin heavy chain in acute myeloid leukemia. Science, 261, 1041-1044.
13. Langabeer, S. E., Walker, H., Gale, R. E., Wheatley, K., Burnett, A. K., Goldstone, A. H. and Linch, D. C. (1997). Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. British Journal of Haematology, 96, 736-739.
14. Claxton, D. F., Liu, P., Hsu, H. B., Marlton, P., Hester, J., Collins, F., Deisseroth, A. B., Rowley, J. D. and Siciliano, M. J. (1994). Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood, 83, 1750-1756.
15. Poirel, H., Radford-Weiss, I., Rack, K.,Troussard, X., Veil, A., Valensi, F., Picard, F., Guesnu, M., Leboeuf, D., Melle, J., Dreyfus, F., Flandrin, G. and Macinlyre, E. (1995). Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemia. Blood. 85, 1313-1322.
16. Shurtleff, S. A., Meyers, S., Hiebert, S. W., Raimondi, S. C., Head, D. R., Willman, C. L., Wolman, S., Slovak, M. L., Carroll, A. J., Behm, F., Hulshof, M. G., Motoroni, T. A., Okuda, T., Liu, P., Collins, F. S. and Downing, J. R. (1995). Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16:16)(p13;q22) in acute myelogenous leukemia. Blood, 85, 3695-3703.
17. van der Reijden, B. A., Lombardo, M., Dauwerse, H. G., Giles, R. H., Muhlematter, D., Bellomo, M. J., Wessels, H. W., Beverstock, G. C., van Ommen, G-J.B., Hagemeijer, A. and Breuning, M. H. (1995). RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood, 86, 277-282.
18. Costello, R., Sainty, D., Lecine, P., Cusenier, A., Mozziconacci, M-J., Arnoulet, C., Maraninchi, D., Gastaut, J-A., Imbert, J., Lafage-Pochitaloff, M. and Gabert, J. (1997). Detection of CBFβ/MYH11 fusion transcripts myeloid leukemia: heterogeneity of cytological and molecular characteristics, Leukemia, 11, 644-650.
19. Hebert, J., Cayuela, J. M., Daniel, M. T., Berger, R. and Sigaux, F. (1994). Detection of minimal residual disease in acute in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood, 84, 2291-2296.
20. Matsuoka, R., Yoshida, M. C., Furutani, Y., Imamura, S., Kanda, N., Yanagisawa, M., Masaki, T. and Takao, A. (1993). Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12. American Journal of Medical Genetics, 46, 61-67.
21. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y. and Shigesada, K. (1993). Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology, 194, 314-331.
22. Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R. and Speck, N. A. (1993). Cloning and characterization of sub-unit of the T-cell recepter and murine leukemia virus enhancer core-binding facter. Molecular and Cellular Biology, 13, 3324-3339.
23. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu. J., Satake, M., Shigesada, K. and Ito, Y. (1993). PEBP2/PEA2 represents a family of transcription factors homologous to the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences USA, 90, 6859-6863.
24. Bae, S. C., Yamaguchi-Iwai, Y., Ogawa, E., Maruyama, M., Inuzuka, M., Kagoshima, H., Shigesada, K., Satake, M. and Ito, Y. (1993). Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene, 8, 809-814.
25. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. and Ohki, M. (1991). The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proceedings of the National Academy of Sciences USA, 88, 10431-10434.
26. Nucifora, G., Birn, D., Espinosa, R., LeBeau, M., Erickson, P., Roulston, D., McKeithan, T. W., Drabkin, H. and Rowley, J. D. (1993). Involvement of the AML1 gene in t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood, 81, 2728-2734.
27. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M. and Hirai, H. (1994). Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. The EMBO Journal, 13, 504-510.
28. Romana, S. P., Poirel, H., Leconiat, M., Flexor, M. A., Mauchauffe, M., Jonvenux, P., Macintyre, E. A., Berger, R. and Bernard, O. A. (1995). High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
29. Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D. and Gilliiland, D. G. (1995). Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences USA, 92, 4917-4921.
30. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L. and Groner, Y. (1994). AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics, 23, 425-432.
31. Meyers, S., Lenny, N., Sun, W. and Hiebert, S. W. (1996). AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene, 13, 303-312.
32. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. and Kishimoto, T. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755-764.
33. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll. J. H. M., Owen, M. J., Mertelsmann, R., Zabel, B. U. and Olsen, B. R. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89, 773-779.
34. + immature cells. British Journal of Haematology, 97, 656-658.
35. Era, T., Asou, N., Kunisada, T., Yamasaki, H., Asou, H., Kamada, N., Nishikawa, S., Yamaguchi, K. and Takatsuki, K. (1995). Identification of two transcripts of AML1/ETO-fused gene in 1(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes, Chromosomes & Cancer, 13, 25-33.
36. Liu, P. P., Hajra, A., Wijimenga, C. and Collin, F. S. (1995). Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood, 85, 2289-2302.
37. Marlton, P., Claxton, D. F., Liu, P., Estey, E. H., Berran, M., Le Beau, M., Testa, J. R., Collins, F. S., Rowley, J. D. and Siciliano, M. J. (1995). Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood, 85, 772-779.
38. Kuss, B. J., Deeley, R. G., Cole, S. P., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A., Nancarrow, J. K., Whitmore, S. A. and Callen, D. F. (1994). Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 343, 1531-1534.
39. van der Reijden, B. A., Martinet, D., Dauwerse, J. G., Giles, R. H., Wessels, J. W., Beverstock, G. C., Smit, B., Muhlematter, D., Bellomo, M. J., Gaben, J., Lafage-Pochitaloff, M., Reiffers, J., Bilhou-Nabera, C., van Ommen, G. J. B., Hagemeijer, A. and Breuning, M. H. (1996). Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia. Leukemia, 10, 1459-1462.
40. Morinaga, S., Osato, M., Yanabe, Y., Takaki, K., Kawano, F., Asou, N., Takatsuki, K., Tsuchiya, H. and Matsuda, I. (1996). Detection of PEBP2β/MYH11 fusion mRNA in acute myelomonocytic leukemia without marrow eosinophilia. Rinsho Ketsueki, 37, 618-623.
41. Asou, N., Sanada, I., Tanaka, K., Hidaka, H., Suzushima, H., Matsuzaki, H., Kawano, F. and Takatsuki, K. (1992). Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 61, 197-200.
42. Yamasaki, H., Era, T., Asou, N., Sanada, I., Matutes, E., Yamaguchi, K. and Takatsuki, K. (1995). High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia. Leukemia, 9, 1147-1153.
43. Mivamoto, T., Akashi, K., Hayashi, S., Oogami, A., Okamura, T., Iwasaki, H., Murakami, M., Harada, M. and Niho, Y. (1997). Pericentric inversion of chromosome 16 and eosinophilia in chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics, 94, 99-102.
44. Quesnel, B., Kantarrijian, H., Bjergaad, J. P., Brault, P., Estey, E., Lai, J. L., Tilly, H., Stoppa, A.M., Archimbaud, E., Harousseau, J. L., Baulers, F. and Fenaux, P. (1993). Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. Journal of Clinical oncology, 11, 2370-2379.
45. Osato, M., Asou, N., Takata, N., Suzushima, H. and Takatsuki, K. (1997). Detection of the PEBP2β/MYH11 fusion transcript in acute myelomonoblastic leukemia (M4Eo) supervening in a patient with adult T-cell leukemia. American Journal of Hematology, 55, 216-217.
46. Adriaansen, H. J., te Boekhorst, P. A. W., Hagemeijer, A. M., van der Schoot, C. E., Delwel, H. R. and van Dongen, J. J. M. (1993). Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(pl3q22) exhibits a specific immunophenotype with CD2 expression. Blood, 81, 3043-3051.
47. + progenitor cells. Blood, 77, 1218-1227.
48. He, X. Y., Antao, V. P., Basila, D., Marx, J. C. and Davis, B. R. (1992). Isolation and molecular characterization of the human CD34 gene. Blood, 79, 2296-2302.
49. Burn, T. C., Satterthwaite, A. B. and Tenen, D. G. (1992). The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood, 80, 3051-3059.
50. Nagai, R., Larson, D. M. and Periasamy, M. (1988). Characterization of a mammalian smooth muscle heavy chain cDNA clone and its expression in various smooth muscle types. Proceedings of the National Academy Sciences USA, 85, 1047-1051.
51. Kiehart, D. P. (1990). Molecular genetic dissection of myosin heavy chain function. Cell, 60, 347-350.
52. Kagoshima, H., Akamatsu, Y., Ito, Y. and Shigesada, K. (1996). Functional Dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. Journal of Biological Chemistry, 271, 33074-33082.
53. Lu, J., Maruyama, M., Satake, M., Bae, S. C., Ogawa, E., Kagoshima, H., Shigesada, K. and Ito, Y. (1995). Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Molecular and Cellular Biology, 15, 1651-1661.
54. Ito, Y. (1996). Structural alterations in the transcription factor PEBP2/CBF linked to four different types of leukemia. Journal of Cancer Research and Clinical Oncology, 122, 266-274.
55. Satake, M., Inuzuka, M., Shigesada, K., Oikawa, K. and Ito, Y. (1992). Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein. PEBP2, in various hematopoietic cells. Japanese Journal of Cancer Research, 83, 714-722.
56. Cameron, S., Taylor, D. S., TePas, E. C., Speck, N. A. and Mathey-Prevot, B. (1994). Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo foot-printing. Blood, 83, 2851-2859.
57. Takahashi, A., Satake, M., Yamaguchi, I. Y., Bae, S-C., Lu, J., Maruyama, M., Zhang, U. W., Oka, H., Arai, N., Arai, K. and Ito, Y. (1995). Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood, 86, 607-616.
58. Nuchprayoon, I., Meyers, S., Scott, L. M., Suzow, J., Hiebert, S. and Friedman, A. D. (1994). PEBP2/CBF, the murine homolog of the human myeloid AML-1 and PEBP2β/CBFβ protooncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Molecular and Cellular Biology, 14, 5558-5568.
59. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. and Downing, J. R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
60. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H. and Speck, N. A. (1996). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences USA, 83, 3444-3449.
61. Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Gu, T-L., Huang, X., Bushweller, J. H., Bories, J-C., Alt, F. W., Ryan, G., Liu, P. P., Wynshaw-Boris, A., Binder, M., Marin-Padilla, M., Sharpe, A. H. and Speck, N. A. (1996). The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell, 87, 697-708.
62. Sasaki, K., Yagi, H., Bronson, R. T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T. and Komori, T. (1996). Absence of fetal liver hematopoiesis in mice deficient in transcriptional cofactor core binding factor β. Proceedings of the National Academy of Sciences USA, 93, 12359-12363.
63. Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marin-Padilla, M., Tenen, D. G., Speck, N. A. and Zhang, D-E. (1997). Embryonic lethality and impairment of haemalopoiesis in mice heterozygous for an AML-ETO fusion gene. Nature Genetics, 15, 303-306.
64. Castilla, L. H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N. A., Eckhaus, M., Marin-Padilla, M., Collins, F. S., Wynshaw-Boris, A. and Liu, P. P. (1996). Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell, 87, 687-696.
65. Sakakura, C., Yamaguchi-Iwai, Y., Satake, M., Bae, S. C., Takahashi, A., Ogawa, E., Hagiwara, A., Takahashi, T., Murakami, A., Makino, K., Nakagawa, T., Kamada, N. and Ito, Y. (1994). Growth inhibition and induction of differentiation of t(8;21) acute mycloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proceedings of the National Academy of Sciences USA, 91, 11723-11727.